Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 16 February

Bell Direct
February 16, 2026

Morning Bell 12 February

Bell Direct
February 12, 2026

Morning Bell 11 February

Bell Direct
February 11, 2026

Morning Bell 10 February

Bell Direct
February 10, 2026

Weekly Wrap 12 December

Bell Direct
December 12, 2025

Morning Bell 11 December

Bell Direct
December 11, 2025

Morning Bell 10 December

Bell Direct
December 10, 2025

Morning Bell 9 December

Bell Direct
December 9, 2025

Morning Bell 8 December

Bell Direct
December 8, 2025

Weekly Wrap 5 December

Bell Direct
December 5, 2025